June 17, 2022 1 min read
The Shils Award is given to companies, people and organizations that have made an impact on the dental community and oral health. It is presented by the Dr. Edward B. Shils Entrepreneurial Fund, a nonprofit organization named after the late Dr. Edward B. Shils and dedicated to innovative leadership in health care.
The organization’s board of directors presented Dr. Primus with the award based on her “innovation and development of many products for fixed prosthodontics, orthodontics and endodontics to enhance dental procedures and advance the dental profession.”
Dr. Primus has made a profound impact on dentistry through her significant advancements with Mineral Trioxide Aggregate (MTA), which is used in vital pulp therapy and endodontics. Dr. Primus has three patents in this area that have enabled her to invent an MTA product that is easier to use. The company she founded, Avalon Biomed, has also made this bioactive pulp treatment and endodontic treatment more affordable for clinicians so that it can be used with patients for whom treatment with an MTA might not be financially viable. With Avalon Biomed now a part of NuSmile Ltd., Dr. Primus is able to continue her bioactive material research that was originally supported by an NIH SBIR grant.
Dr. Primus stated, “I am delighted and honored to receive the Shils Award. Throughout my dental career, inventing useful biomaterials has remained at the forefront of my goals. The Dr. Edward B. Shils Entrepreneurial Fund has provided me further inspiration to continue to innovate for better dental treatments.”